Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer

Murray Korc1

  • 1Department of Developmental and Cell Biology, Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California.